Zscaler (ZS) 10-Q8 Mar 232023 Q2 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	6 Months Ended
Cover Page - shares	Jan. 31, 2023	Feb. 28, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2023
Document Transition Report	false
Entity File Number	001-38413
Entity Registrant Name	ZSCALER, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1173892
Entity Address, Address Line One	120 Holger Way
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	533-0288
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	ZS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares Outstanding		145,120,095
Entity Central Index Key	0001713683
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,257,012	$ 1,013,210
Short-term investments	648,332	718,129
Accounts receivable, net	358,614	399,745
Deferred contract acquisition costs	96,105	86,210
Prepaid expenses and other current assets	56,046	39,353
Total current assets	2,416,109	2,256,647
Property and equipment, net	200,468	160,633
Operating lease right-of-use assets	69,848	72,357
Deferred contract acquisition costs, noncurrent	219,046	210,792
Acquired intangible assets, net	26,716	31,819
Goodwill	78,547	78,547
Other noncurrent assets	29,222	21,870
Total assets	3,039,956	2,832,665
Current liabilities:
Accounts payable	33,632	26,154
Accrued expenses and other current liabilities	43,547	46,496
Accrued compensation	97,293	111,948
Deferred revenue	1,000,359	923,749
Operating lease liabilities	29,173	26,100
Total current liabilities	1,204,004	1,134,447
Convertible senior notes, net	1,140,516	968,674
Deferred revenue, noncurrent	111,521	97,374
Operating lease liabilities, noncurrent	46,233	50,948
Other noncurrent liabilities	9,025	7,922
Total liabilities	2,511,299	2,259,365
Commitments and contingencies (Note 9)
Stockholders’ Equity
Common stock; $0.001 par value; 1,000,000 shares authorized as of January 31, 2023 and July 31, 2022; 145,087 and 143,038 shares issued and outstanding as of January 31, 2023 and July 31, 2022, respectively	145	143
Additional paid-in capital	1,547,203	1,590,885
Accumulated other comprehensive loss	(5,037)	(25,850)
Accumulated deficit	(1,013,654)	(991,878)
Total stockholders’ equity	528,657	573,300
Total liabilities and stockholders’ equity	$ 3,039,956	$ 2,832,665

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jan. 31, 2023	Jul. 31, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	145,087,000	143,038,000
Common stock, shares outstanding (in shares)	145,087,000	143,038,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Income Statement [Abstract]
Revenue	$ 387,598	$ 255,563	$ 743,146	$ 486,080
Cost of revenue	87,604	57,783	164,301	109,952
Gross profit	299,994	197,780	578,845	376,128
Operating expenses:
Sales and marketing	235,945	175,073	464,781	328,859
Research and development	85,765	69,195	160,711	134,411
General and administrative	43,522	37,444	87,678	71,161
Total operating expenses	365,232	281,712	713,170	534,431
Loss from operations	(65,238)	(83,932)	(134,325)	(158,303)
Interest income	12,669	557	20,534	1,030
Interest expense	(1,333)	(14,040)	(2,664)	(27,875)
Other income (expense), net	141	(844)	(722)	(1,433)
Loss before income taxes	(53,761)	(98,259)	(117,177)	(186,581)
Provision for income taxes	3,692	2,161	8,438	4,640
Net loss	$ (57,453)	$ (100,420)	$ (125,615)	$ (191,221)
Net loss per share, basic (in dollars per share)	$ (0.40)	$ (0.71)	$ (0.87)	$ (1.37)
Net loss per share, diluted (in dollars per share)	$ (0.40)	$ (0.71)	$ (0.87)	$ (1.37)
Weighted-average shares used in computing net loss per share, basic (in shares)	144,511	140,515	144,001	139,901
Weighted-average shares used in computing net loss per share, diluted (in shares)	144,511	140,515	144,001	139,901

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (57,453)	$ (100,420)	$ (125,615)	$ (191,221)
Available-for-sale securities:
Change in net unrealized gains (losses) on available-for-sale securities	4,501	(4,247)	1,853	(5,411)
Cash flow hedging instruments:
Change in net unrealized gains (losses)	24,019	(3,164)	9,980	(4,469)
Net realized gains reclassified into net loss	4,267	876	8,980	1,231
Net change on cash flow hedges	28,286	(2,288)	18,960	(3,238)
Other comprehensive income (loss)	32,787	(6,535)	20,813	(8,649)
Comprehensive loss	$ (24,666)	$ (106,955)	$ (104,802)	$ (199,870)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	$ 1,131,006		$ (650)	$ (601,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			664
Issuance of common stock upon exercise of stock options	4,871			4,871
Issuance of common stock under the employee stock purchase plan (in shares)			109
Issuance of common stock under the employee stock purchase plan	11,509			11,509
Vesting of restricted stock units and other stock issuances (in shares)			1,628
Vesting of restricted stock units and other stock issuances	1,703		$ 2	1,701
Stock-based compensation	192,259			192,259
Other comprehensive income (loss)	(8,649)					(8,649)
Net loss	(191,221)						(191,221)
Ending balance (in shares) at Jan. 31, 2022			141,063
Ending balance at Jan. 31, 2022	539,367		$ 141	1,341,346		(9,299)	(792,821)
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	1,131,006		(650)	(601,600)
Ending balance (in shares) at Jul. 31, 2022	143,038		143,038
Ending balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	1,590,885	$ (273,738)	(25,850)	(991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Beginning balance (in shares) at Oct. 31, 2021			140,032
Beginning balance at Oct. 31, 2021	$ 530,199		$ 140	1,225,224		(2,764)	(692,401)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			277
Issuance of common stock upon exercise of stock options	2,227			2,227
Issuance of common stock under the employee stock purchase plan (in shares)			109
Issuance of common stock under the employee stock purchase plan	11,509			11,509
Vesting of restricted stock units and other stock issuances (in shares)			645
Vesting of restricted stock units and other stock issuances	1,703		$ 1	1,702
Stock-based compensation	100,684			100,684
Other comprehensive income (loss)	(6,535)					(6,535)
Net loss	(100,420)						(100,420)
Ending balance (in shares) at Jan. 31, 2022			141,063
Ending balance at Jan. 31, 2022	$ 539,367		$ 141	1,341,346		(9,299)	(792,821)
Beginning balance (in shares) at Jul. 31, 2022	143,038		143,038
Beginning balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	1,590,885	$ (273,738)	(25,850)	(991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	224		224
Issuance of common stock upon exercise of stock options	$ 2,104			2,104
Issuance of common stock under the employee stock purchase plan (in shares)			115
Issuance of common stock under the employee stock purchase plan	11,410			11,410
Vesting of restricted stock units and other stock issuances (in shares)			1,710
Vesting of restricted stock units and other stock issuances	0		$ 2	(2)
Stock-based compensation	216,544			216,544
Other comprehensive income (loss)	20,813					20,813
Net loss	$ (125,615)						(125,615)
Ending balance (in shares) at Jan. 31, 2023	145,087		145,087
Ending balance at Jan. 31, 2023	$ 528,657		$ 145	1,547,203		(5,037)	(1,013,654)
Beginning balance (in shares) at Oct. 31, 2022			144,210
Beginning balance at Oct. 31, 2022	431,275		$ 144	1,425,156		(37,824)	(956,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			115
Issuance of common stock upon exercise of stock options	1,122			1,122
Issuance of common stock under the employee stock purchase plan (in shares)			115
Issuance of common stock under the employee stock purchase plan	11,410			11,410
Vesting of restricted stock units and other stock issuances (in shares)			647
Vesting of restricted stock units and other stock issuances	0		$ 1	(1)
Stock-based compensation	109,516			109,516
Other comprehensive income (loss)	32,787					32,787
Net loss	$ (57,453)						(57,453)
Ending balance (in shares) at Jan. 31, 2023	145,087		145,087
Ending balance at Jan. 31, 2023	$ 528,657		$ 145	$ 1,547,203		$ (5,037)	$ (1,013,654)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Jan. 31, 2023	Jan. 31, 2022
Cash Flows From Operating Activities
Net loss		$ (125,615)	$ (191,221)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization expense		25,241	19,005
Amortization expense of acquired intangible assets		5,103	4,457
Amortization of deferred contract acquisition costs		46,053	31,038
Amortization of debt discount and issuance costs		1,945	27,156
Non-cash operating lease costs		14,988	12,411
Stock-based compensation expense		214,911	188,891
Amortization (accretion) of investments purchased at a premium (discount)		(1,433)	4,662
Deferred income taxes		9	(659)
Other		(1,480)	295
Changes in operating assets and liabilities, net of effects of business combinations
Accounts receivable		40,800	(12,622)
Deferred contract acquisition costs		(64,202)	(58,513)
Prepaid expenses, other current and noncurrent assets		(7,800)	4,903
Accounts payable		5,228	(103)
Accrued expenses, other current and noncurrent liabilities		5,899	5,029
Accrued compensation		(17,651)	(9,759)
Deferred revenue		90,862	129,594
Operating lease liabilities		(14,920)	(13,031)
Net cash provided by operating activities		217,938	141,533
Cash Flows From Investing Activities
Purchases of property, equipment and other assets		(43,883)	(20,442)
Capitalized internal-use software		(15,623)	(8,275)
Payments for business acquisitions, net of cash acquired		0	(380)
Purchase of strategic investments		(1,200)	0
Purchases of short-term investments		(513,743)	(624,254)
Proceeds from maturities of short-term investments		586,801	629,411
Net cash provided by (used in) investing activities		12,352	(23,940)
Cash Flows From Financing Activities
Proceeds from issuance of common stock upon exercise of stock options		2,104	4,871
Proceeds from issuance of common stock under the employee stock purchase plan		11,410	11,509
Payment of deferred consideration related to business acquisitions		0	(50)
Other		(2)	(2)
Net cash provided by financing activities		13,512	16,328
Net increase in cash and cash equivalents	[1]	243,802	133,921
Cash and cash equivalents at beginning of period	[1]	1,013,210	275,898
Cash and cash equivalents at end of period	[1]	1,257,012	409,819
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes, net of tax refunds		3,008	3,777
Cash paid for interest expense		719	719
Non-Cash Activities
Operating lease right-of-use assets obtained in exchange for operating lease obligations, net of terminations		12,136	10,087
Net change in purchased equipment included in accounts payable and accrued expenses		$ 2,839	$ 513

[1]We did not hold restricted cash for any periods presented.

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	6 Months Ended
Business and Summary of Significant Accounting Policies	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies Description of the Business Zscaler, Inc. ("Zscaler," the "Company," "we," "us," or "our") is a cloud security company that developed a platform incorporating core security functionalities needed to enable fast and secure access to cloud resources based on identity, context and organization’s policies. Our solution is a purpose-built, multi-tenant, distributed cloud platform that incorporates the security functionality needed to enable users, applications, and devices to safely and efficiently utilize authorized applications and services based on an organization’s business policies. We deliver our solutions using a software-as-a-service ("SaaS") business model and sell subscriptions to customers to access our cloud platform, together with related support services. We were incorporated in Delaware in September 2007 and conduct business worldwide, with presence in North America, Europe and Asia. Our headquarters are in San Jose, California. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2022 (the "Fiscal 2022 Form 10-K"), as filed with the SEC on September 15, 2022. Interim Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of July 31, 2022 was derived from the audited consolidated financial statements as of that date. The accompanying interim condensed consolidated financial statements, including the condensed consolidated balance sheet as of January 31, 2023, the condensed consolidated statements of operations for the three and six months ended January 31, 2023 and 2022, the condensed consolidated statements of comprehensive loss for the three and six months ended January 31, 2023 and 2022, the condensed consolidated statements of stockholders’ equity for the three and six months ended January 31, 2023 and 2022 and the condensed consolidated statements of cash flows for the six months ended January 31, 2023 and 2022 are unaudited. The related financial data and the other financial information disclosed in the accompanying notes to these condensed consolidated financial statements are also unaudited. These interim unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual consolidated financial statements and, in our opinion, include all normal recurring adjustments necessary to state fairly our quarterly results. The results of operations for the three and six months ended January 31, 2023 are not necessarily indicative of the results to be expected for our fiscal year ending July 31, 2023 or for any other future fiscal year or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal use software development costs, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value and effective interest rate of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including effects of COVID-19 and inflation, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained . Fiscal Year Our fiscal year ends on July 31. References to fiscal 2023, for example, refer to our fiscal year ending July 31, 2023. Significant Accounting Policies Our significant accounting policies are described in the Fiscal 2022 Form 10-K. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and related notes for the three and six months ended January 31, 2023 other than for the adoption of new accounting guidance related to convertible senior notes effective August 1, 2022, further described below. Recently Adopted Accounting Pronouncements In June 2020, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06"). This standard removes the separation model for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. We adopted this standard effective on August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. In accordance with the adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. This standard resulted in our convertible senior notes being accounted for as a single unit of debt and we will no longer be required to record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. Prior to the adoption of this standard, we used the treasury stock method to calculate the potentially diluted effect of the convertible

Revenue Recognition

Revenue Recognition	6 Months Ended
Revenue Recognition	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Subscription and support revenue is recognized over time and accounted for approximately 97% of our revenue for each of the three and six months ended January 31, 2023 and 2022, respectively. The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) United States $ 193,508 50 % $ 125,419 49 % $ 369,023 50 % $ 238,832 49 % Europe, Middle East and Africa 124,742 32 % 88,174 35 % 241,749 32 % 168,723 35 % Asia Pacific 57,602 15 % 36,029 14 % 109,858 15 % 67,080 14 % Other 11,746 3 % 5,941 2 % 22,516 3 % 11,445 2 % Total $ 387,598 100 % $ 255,563 100 % $ 743,146 100 % $ 486,080 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) Channel partners $ 358,165 92 % $ 238,947 93 % $ 687,522 93 % $ 454,550 94 % Direct customers 29,433 8 % 16,616 7 % 55,624 7 % 31,530 6 % Total $ 387,598 100 % $ 255,563 100 % $ 743,146 100 % $ 486,080 100 % Significant Customers No single customer accounted for 10% or more of the total revenue or the total balance of accounts receivable, net in the periods presented. Contract Balances Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. Deferred revenue, including current and noncurrent balances, as of January 31, 2023 and July 31, 2022 was $1,111.9 million and $1,021.1 million, respectively. In the six months ended January 31, 2023 and 2022, we recognized revenue of $603.8 million and $378.6 million, respectively, that was included in the corresponding contract liability balance at the beginning of these periods. Remaining Performance Obligations The typical subscription and support term is one Costs to Obtain and Fulfill a Contract We capitalize sales commission and associated payroll taxes paid to internal sales personnel that are incremental to the acquisition of channel partner and direct customer contracts. These costs are recorded as deferred contract acquisition costs in the condensed consolidated balance sheets. The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Beginning balance $ 301,472 $ 216,103 $ 297,002 $ 207,030 Capitalization of contract acquisition costs 37,407 34,528 64,202 58,513 Amortization of deferred contract acquisition costs (23,728) (16,126) (46,053) (31,038) Ending balance $ 315,151 $ 234,505 $ 315,151 $ 234,505 The outstanding balance of the deferred contract acquisition costs consisted of the following: January 31, 2023 July 31, 2022 (in thousands) Deferred contract acquisition costs, current $ 96,105 $ 86,210 Deferred contract acquisition costs, noncurrent 219,046 210,792 Total deferred contract acquisition costs $ 315,151 $ 297,002 Sales commissions accrued but not paid as of January 31, 2023 and July 31, 2022, totaled $23.5 million and $47.2 million, respectively, which are included within accrued compensation in the condensed consolidated balance sheets.

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	6 Months Ended
Cash Equivalents and Short-Term Investments	Jan. 31, 2023
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments Cash equivalents and short-term investments consisted of the following as of January 31, 2023: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 436,581 $ — $ — $ 436,581 U.S. treasury securities 26,933 — (2) 26,931 U.S. government agency securities 369,324 — (79) 369,245 Corporate debt securities 117,303 — — 117,303 Total cash equivalents $ 950,141 $ — $ (81) $ 950,060 Short-term investments: U.S. treasury securities $ 31,533 $ 40 $ — $ 31,573 U.S. government agency securities 276,278 — (6,471) 269,807 Corporate debt securities 350,578 337 (3,963) 346,952 Total short-term investments $ 658,389 $ 377 $ (10,434) $ 648,332 Total cash equivalents and short-term investments $ 1,608,530 $ 377 $ (10,515) $ 1,598,392 Cash equivalents and short-term investments consisted of the following as of July 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 247,613 $ — $ — $ 247,613 U.S. treasury securities 202,778 — (70) 202,708 U.S. government agency securities 135,525 2 (38) 135,489 Corporate debt securities 106,272 — — 106,272 Total cash equivalents $ 692,188 $ 2 $ (108) $ 692,082 Short-term investments: U.S. treasury securities $ 96,089 $ 10 $ (251) $ 95,848 U.S. government agency securities 339,957 6 (6,628) 333,335 Corporate debt securities 293,968 — (5,022) 288,946 Total short-term investments $ 730,014 $ 16 $ (11,901) $ 718,129 Total cash equivalents and short-term investments $ 1,422,202 $ 18 $ (12,009) $ 1,410,211 The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of January 31, 2023: Amortized Fair Value (in thousands) Due within one year $ 427,636 $ 423,153 Due between one to three years 230,753 225,179 Total $ 658,389 $ 648,332 Short-term investments that were in an unrealized loss position as of January 31, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 24,983 $ — $ — $ — $ 24,983 $ — U.S. government agency securities 75,709 (23) 183,088 (6,448) 258,797 (6,471) Corporate debt securities 49,577 (181) 141,110 (3,782) 190,687 (3,963) Total $ 150,269 $ (204) $ 324,198 $ (10,230) $ 474,467 $ (10,434) Short-term investments that were in an unrealized loss position as of July 31, 2022 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 80,833 $ (251) $ — $ — $ 80,833 $ (251) U.S. government agency securities 230,670 (5,150) 50,134 (1,478) 280,804 (6,628) Corporate debt securities 155,968 (3,947) 71,127 (1,075) 227,095 (5,022) Total $ 467,471 $ (9,348) $ 121,261 $ (2,553) $ 588,732 $ (11,901) We review the individual securities that have unrealized losses in our short-term investment portfolio on a regular basis. We evaluate, among others, whether we have the intention to sell any of these investments and whether it is not more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met in any period presented. We additionally evaluate whether the decline in fair value of the corporate debt securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, we determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and non-credit related factors. Accordingly, we determined that an allowance for credit losses was unnecessary for our short-term investments as of January 31, 2023 and July 31, 2022. As of January 31, 2023 and July 31, 2022, we recorded $1.7 million and $1.3 million, respectively, of accrued interest receivable within prepaid expenses and other current assets in the condensed consolidated balance sheets.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
Fair Value Measurements	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our money market funds are classified within Level I due to the highly liquid nature of these assets and have quoted prices in active markets. Certain of our investments in available-for-sale securities (i.e., U.S. treasury securities, U.S. government agency securities and corporate debt securities), as well as our assets and liabilities arising from our foreign currency forward contracts, are classified within Level II. The fair value of our Level II financial assets and liabilities is determined by using inputs based on non-binding market consensus prices that are primarily corroborated by observable market data or quoted market prices for similar instruments, for substantially the full term of the financial assets and liabilities. Assets and liabilities that are measured at fair value on a recurring basis as of January 31, 2023, consisted of the following: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 436,581 $ 436,581 $ — $ — U.S. treasury securities 26,931 — 26,931 — U.S. government agency securities 369,245 — 369,245 — Corporate debt securities 117,303 — 117,303 — Total cash equivalents $ 950,060 $ 436,581 $ 513,479 $ — Short-term investments: U.S. treasury securities $ 31,573 $ — $ 31,573 $ — U.S. government agency securities 269,807 — 269,807 — Corporate debt securities 346,952 — 346,952 — Total short-term investments $ 648,332 $ — $ 648,332 $ — Total cash equivalents and short-term investments $ 1,598,392 $ 436,581 $ 1,161,811 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 7,770 $ — $ 7,770 $ — Foreign currency contract assets-noncurrent (2) $ 5,368 $ — $ 5,368 $ — Foreign currency contracts liabilities-current (3) $ 4,084 $ — $ 4,084 $ — Foreign currency contracts liabilities-noncurrent (4) $ 145 $ — $ 145 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 617 $ — $ 617 $ — Foreign currency contracts liabilities-current (3) $ 2,309 $ — $ 2,309 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. We did not have transfers between levels of the fair value hierarchy of assets measured at fair value during the periods presented. Refer to Note 8, Convertible Senior Notes, for the carrying amount and estimated fair value of our convertible senior notes as of January 31, 2023 and July 31, 2022.

Property and Equipment and Purc

Property and Equipment and Purchased Intangible Assets	6 Months Ended
Property and Equipment and Purchased Intangible Assets	Jan. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: January 31, 2023 July 31, 2022 (in thousands) Hosting equipment $ 234,101 $ 191,037 Capitalized internal-use software 96,343 72,267 Computers and equipment 7,464 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,024 1,022 Leasehold improvements 7,339 7,339 Total property and equipment, gross 347,582 279,750 Less: Accumulated depreciation and amortization (147,114) (119,117) Total property and equipment, net $ 200,468 $ 160,633 Purchased intangible assets consist of internet protocol (IP) addresses, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of January 31, 2023, their historical cost and accumulated amortization were $8.6 million and $1.2 million, respectively. As of July 31, 2022, their historical cost and accumulated amortization were $6.4 million and $0.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $13.4 million and $10.0 million for the three months ended January 31, 2023 and 2022, respectively, and $25.2 million and $19.0 million for the six months ended January 31, 2023 and 2022, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $2.0 million and $1.0 million for the three months ended January 31, 2023 and 2022, respectively, and $3.7 million and $1.9 million for the six months ended January 31, 2023 and 2022, respectively.
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: January 31, 2023 July 31, 2022 (in thousands) Hosting equipment $ 234,101 $ 191,037 Capitalized internal-use software 96,343 72,267 Computers and equipment 7,464 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,024 1,022 Leasehold improvements 7,339 7,339 Total property and equipment, gross 347,582 279,750 Less: Accumulated depreciation and amortization (147,114) (119,117) Total property and equipment, net $ 200,468 $ 160,633 Purchased intangible assets consist of internet protocol (IP) addresses, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of January 31, 2023, their historical cost and accumulated amortization were $8.6 million and $1.2 million, respectively. As of July 31, 2022, their historical cost and accumulated amortization were $6.4 million and $0.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $13.4 million and $10.0 million for the three months ended January 31, 2023 and 2022, respectively, and $25.2 million and $19.0 million for the six months ended January 31, 2023 and 2022, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $2.0 million and $1.0 million for the three months ended January 31, 2023 and 2022, respectively, and $3.7 million and $1.9 million for the six months ended January 31, 2023 and 2022, respectively.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	6 Months Ended
Goodwill and Acquired Intangible Assets	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill The carrying amount of goodwill was $78.5 million as of January 31, 2023 and July 31, 2022. Acquired Intangible Assets Acquired intangible assets consist of developed technology and customer relationships acquired through our business combinations and asset acquisitions. Acquired intangible assets are amortized using the straight-line method over their estimated useful lives. Acquired intangible assets subject to amortization consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount July 31, 2022 Additions January 31, 2023 July 31, 2022 Amortization Expense January 31, 2023 July 31, 2022 January 31, 2023 (in thousands) Developed technology $ 48,356 $ — $ 48,356 $ (18,972) $ (4,747) $ (23,719) $ 29,384 $ 24,637 Customer relationships 3,560 — 3,560 (1,125) (356) (1,481) 2,435 2,079 Total $ 51,916 $ — $ 51,916 $ (20,097) $ (5,103) $ (25,200) $ 31,819 $ 26,716 Amortization expense of acquired intangible assets for the three and six months ended January 31, 2023 was $2.6 million and $5.1 million, respectively, and for the three and six months ended January 31, 2022 was $2.2 million and $4.5 million, respectively. Amortization expense of developed technology and customer relationships is included primarily within cost of revenue and sales and marketing expenses, respectively, in the condensed consolidated statements of operations. Future amortization expense of acquired intangible assets consisted of the following: January 31, 2023 Year ending July 31, (in thousands) 2023 (remaining six months) $ 4,817 2024 8,481 2025 7,778 2026 4,232 2027 1,408 Total $ 26,716

Derivative Instruments

Derivative Instruments	6 Months Ended
Derivative Instruments	Jan. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments As a global business, we are exposed to foreign currency exchange rate risk. Substantially all of our revenue is transacted in U.S. dollars; however, a portion of our cost of revenue and operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. In order to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts, which we designate as cash flow hedges. All cash flow hedges were considered effective during the three and six months ended January 31, 2023 and 2022. We also use foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. The outstanding non-designated derivative instruments are carried at fair value with change in fair value recorded in other expense, net in the condensed consolidated statement of operations in the same period as the changes in fair value from the remeasurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. These foreign exchange contracts typically have maturities of approximately one As of January 31, 2023 and July 31, 2022, the total notional amount of our outstanding designated foreign currency forward contracts was $409.2 million and $293.4 million, respectively, and for our outstanding non-designated foreign currency forward contracts was $156.2 million and $126.4 million, respectively. The maximum length of time over which forecasted foreign currency denominated operating expenses are hedged is 24 months. As of January 31, 2023, an estimated $2.9 million of the unrealized losses related to our cash flow hedges are expected to be released into earnings over the next 12 months. Refer to Note 4, Fair Value Measurements, for the fair value of our derivative instruments as reported on the condensed consolidated balance sheet as of January 31, 2023 and July 31, 2022. During the three and six months ended January 31, 2023 and 2022, changes in the fair value of our non-designated derivative instruments recorded within other expense, net in the condensed consolidated statements of operations were not material. During the three months ended January 31, 2023 and 2022, we recognized a gain of $24.0 million and a loss of $3.2 million, respectively, in accumulated other comprehensive income (loss) ("AOCI") related to our cash flow hedges. During the six months ended January 31, 2023 and 2022, we recognized a gain of $10.0 million and a loss of $4.5 million, respectively, in AOCI related to our cash flow hedges. The following table presents information about (gains) losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations for three and six months ended January 31, 2023 and 2022 : Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Classification: Cost of revenue $ 706 $ 64 $ 1,413 $ 69 Sales and marketing 2,757 760 6,053 1,140 Research and development 583 24 1,047 (2) General and administrative 221 28 467 24 Total $ 4,267 $ 876 $ 8,980 $ 1,231 Our derivative contracts expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the underlying contracts. We mitigate this credit risk by transacting with major financial institutions with high credit ratings and standards. We periodically assess the creditworthiness of our counterparties to ensure they continue to meet our credit quality requirements. We also enter into master netting arrangements, which permit net settlement of transactions with the same counterparty. The potential impact of these rights of set-off associated with our derivative instruments was not material as of January 31, 2023 and July 31, 2022. We are not required to pledge, and are not entitled to receive, cash collateral related to these derivative instruments. We do not enter into derivative contracts for trading or speculative purposes.

Convertible Senior Notes

Convertible Senior Notes	6 Months Ended
Convertible Senior Notes	Jan. 31, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 25, 2020, we issued $1,150.0 million in aggregate principal amount of 0.125% Convertible Senior Notes due 2025 (the “Notes”), including the exercise in full by the initial purchasers of the Notes of their option to purchase an additional $150.0 million principal amount of the Notes. The Notes are unsecured obligations and bear interest at a rate of 0.125% per year and interest is payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes mature on July 1, 2025, unless earlier converted, redeemed or repurchased. The total net proceeds from the offering, after deducting initial purchase discounts and other debt issuance costs, was $1,130.5 million. Refer to Note 9, Convertible Senior Notes, in the Notes to Consolidated Financial Statements included in our Fiscal 2022 Form 10-K for further information on the Notes. During the three and six months ended January 31, 2023, the conditions allowing holders of the Notes to convert were not met. The net carrying amount of the liability component of the Notes consisted of the following: January 31, July 31, 2023 2022 (in thousands) Principal amount $ 1,149,993 $ 1,149,995 Less: Unamortized debt discount (1) — 172,169 Unamortized debt issuance costs (1) 9,477 9,152 Net carrying amount $ 1,140,516 $ 968,674 (1) Effective August 1, 2022, we adopted ASU 2020-06 using the modified retrospective method under which prior period amounts have not been adjusted. The adoption of this standard resulted in the elimination of the debt discount and related amortization as interest expense and the classification of the portion of the debt issuance costs initially allocated to equity within the carrying amount of our senior convertible notes, which is recognized as interest expense post adoption of the standard. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Contractual interest expense $ 360 $ 359 $ 719 $ 719 Amortization of debt discount (1) — 12,990 — 25,785 Amortization of debt issuance costs (1) 973 691 1,945 1,371 Total $ 1,333 $ 14,040 $ 2,664 $ 27,875 (1) The decrease in total interest expense for the three and six months ended January 31, 2023, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies. The total fair value of the Notes was $1,259.9 million and $1,418.5 million as of January 31, 2023 and July 31, 2022, respectively. The fair value was determined based on the closing trading price per $1,000 of the Notes as of the last day of trading for the period. We consider the fair value of the Notes as of January 31, 2023 to be a Level II measurement as they are not actively traded. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. In connection with the pricing of the Notes, we entered into capped call transactions with the option counterparties (the "Capped Calls"). The Capped Calls each have an initial strike price of $150.80 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $246.76 per share, subject to certain adjustments. The Capped Calls are generally expected to reduce potential dilution to our common stock upon any conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted Notes, as the case may be, with such reduction and/or offset subject to a cap. During the three and six months ended January 31, 2023 and 2022 , we have not exercised any Capped Call options. Refer to Note 9, Convertible Senior Notes, in the Notes to Consolidated Financial Statements included in our Fiscal 2022 Form 10-K for further information on the Capped Calls.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various third parties to purchase products and services such as technology equipment, subscription-based cloud service arrangements, corporate and marketing events and consulting services. During the three and six months ended January 31, 2023, there have been no material changes outside the ordinary course of business to our non-cancelable purchase commitments from those disclosed in our Fiscal 2022 Form 10-K. Other Commitments As of January 31, 2023 and July 31, 2022, we had outstanding irrevocable standby unsecured letters of credits for an aggregate value of $2.1 million with a bank, which serve as security under certain real estate leases. Legal Matters We are a party to various litigation matters from time to time and subject to claims that arise in the ordinary course of business, including patent, commercial, product liability, employment, class action, whistleblower and other litigation and claims, as well as governmental and other regulatory investigations and proceedings. In addition, third parties may from time to time assert claims against us in the form of letters and other communications. There is no pending or threatened legal proceeding to which we are a party that, in our opinion, is likely to have a material adverse effect on our future financial results or operations; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. The expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change and could adversely affect our results of operations.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
Stock-Based Compensation	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan Equity incentive awards which may be granted to eligible participants under our Fiscal Year 2018 Equity Incentive Plan (the "Plan") include restricted stock units, restricted stock, stock options, nonstatutory stock options, stock appreciation rights, performance units and performance shares. Stock Options The activity of stock options for the six months ended January 31, 2023 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2022 1,673 $ 11.81 2.5 $ 240,286 Exercised (224) 9.20 29,977 Canceled, forfeited or expired (5) 7.61 Balance as of January 31, 2023 1,444 $ 12.24 2.1 $ 161,644 Exercisable and expected to vest as of July 31, 2022 1,501 $ 10.78 2.4 $ 216,539 Exercisable and expected to vest as of January 31, 2023 1,375 $ 11.60 2.1 $ 154,769 The aggregate intrinsic value of the options exercised represents the difference between the fair value of our common stock on the date of exercise and their exercise price. The total intrinsic value of options exercised for the six months ended January 31, 2023 and 2022 was $30.0 million and $182.6 million, respectively. There were no stock options granted during the periods presented. Restricted Stock Units and Performance Stock Awards The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the six months ended January 31, 2023: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2022 7,388 $ 157.17 $ 1,145,526 Granted 2,365 157.94 Vested (1,666) 150.83 254,957 Canceled or forfeited (738) 168.08 Balance as of January 31, 2023 7,349 $ 157.76 $ 912,413 As of January 31, 2023, there were 0.1 million outstanding PSAs for which the performance metrics have not been defined as of such date. Accordingly, such awards are not considered granted for accounting purposes as of January 31, 2023 and have been excluded from the above table. Employee Stock Purchase Plan In fiscal 2018, we adopted the Fiscal Year 2018 Employee Stock Purchase Plan (the "ESPP"). During the three months ended January 31, 2023, employees purchased 0.1 million shares of our common stock under the ESPP at an average purchase price of $99.59 per share, resulting in total cash proceeds of $11.4 million. ESPP employee payroll contributions accrued as of January 31, 2023 and July 31, 2022, were $9.2 million and $4.7 million, respectively, and are included within accrued compensation in the condensed consolidated balance sheets. Payroll contributions accrued as of January 31, 2023 will be used to purchase shares at the end of the current ESPP purchase period ending on June 15, 2023. Payroll contributions ultimately used to purchase shares are reclassified to stockholders’ equity on the purchase date. In December 2022, certain outstanding ESPP offering periods were reset and automatically rolled over into a new ESPP offering period that started on December 15, 2022. The reset was accounted for as a modification, which resulted in incremental stock-based compensation of $8.3 million that will be recognized over the remaining term of the modified ESPP offering periods, ranging from approximately six months to 18 months. The fair value of the purchase right for the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Six Months Ended January 31, 2023 2022 Expected term (in years) 0.5 -2.0 0.5 - 2.0 Expected stock price volatility 62.4% - 75.9% 44.1% - 57.4% Risk-free interest rate 4.2% - 4.7% 0.1% - 0.7% Dividend yield 0.0% 0.0% Departure of the President of the Company In October 2022, our President, who led research and development activities, resigned from his position as President of the Company, but will continue serving as a member of our Board of Directors. In connection with his resignation as President of the Company, we recognized a reversal of stock-based compensation of $9.9 million associated with the cancellation of unvested incentive equity awards, which was recognized in research and development expenses in the condensed consolidated statement of operations for the six months ended January 31, 2023. Modification of Equity Awards During the three months ended October 31, 2022, we modified the equity awards of certain employees. In accordance with the accounting for the modification, we recognized stock-based compensation expense of $5.6 million in research and development expenses in the condensed consolidated statement of operations for the six months ended January 31, 2023. Stock-based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Cost of revenue $ 9,410 $ 5,481 $ 17,842 $ 10,467 Sales and marketing 54,213 44,586 107,848 85,307 Research and development 29,005 28,626 53,536 55,885 General and administrative 17,110 20,295 35,685 37,232 Total $ 109,738 $ 98,988 $ 214,911 $ 188,891 During the three months ended January 31, 2023 and 2022, we capitalized stock-based compensation associated with the development of software for internal-use of $4.3 million and $2.7 million, respectively. During the six months ended January 31, 2023 and 2022, the amount capitalized was $8.3 million and $5.2 million, respectively.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, we make a cumulative adjustment in such period. Our quarterly tax provision, and estimate of our annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how we do business, and tax law developments. Our estimated annual effective tax rate for the year differs from the U.S. statutory rate of 21% as a result of our U.S. losses for which no benefit will be realized, as well as our foreign operations which are subject to tax rates that differ from those in the United States. We recorded provision for income taxes of $3.7 million and $2.2 million for the three months ended January 31, 2023 and 2022, respectively, and $8.4 million and $4.6 million for the six months ended January 31, 2023 and 2022, respectively. The increase in the provision for income taxes for the six months ended January 31, 2023 was due to the increase in our pre-tax income in the foreign jurisdictions in which we conduct business and the effects of a tax law change related to mandatory capitalization of research and development expenses for tax years starting January 1, 2022. We are subject to income tax in the United States as well as other tax jurisdictions in which we conduct business. Earnings from our non-U.S. operations are subject to income taxes in the countries in which we operate. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. We assess our ability to realize the deferred tax assets on a quarterly basis and we establish a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. We weigh all available positive and negative evidence, including our earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including our history of losses in certain jurisdictions, we believe that it is more likely than not that our U.S. federal, state, and the United Kingdom ("U.K.") deferred tax assets will not be realized. Accordingly, we have maintained a valuation allowance on our U.S. federal, state and U.K. deferred tax assets.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
Net Loss Per Share	Jan. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) (in thousands) Net loss $ (57,453) $ (100,420) $ (125,615) $ (191,221) Weighted-average shares used in computing net loss per share, basic and diluted 144,511 140,515 144,001 139,901 Net loss per share, basic and diluted $ (0.40) $ (0.71) $ (0.87) $ (1.37) Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented. Prior to the adoption of ASU 2020-06, we calculated the potential dilutive effect of the Notes under the treasury stock method. As a result, only the amount by which the conversion value exceeded the aggregate principal amount of the Notes (the “conversion spread”) was considered in the diluted earnings per share computation. The conversion spread only had a dilutive impact on diluted net income per share when the average market price of our common stock for a given reporting period exceeded the initial conversion price of $150.80 per share for the Notes. Upon the adoption of ASU 2020-06 on August 1, 2022, we calculated the potential dilutive effect of the Notes under the if-converted method. Under this method, diluted earnings per share is determined by assuming that all of the Notes were converted into shares of our common stock at the beginning of the reporting period. In connection with the issuance of the Notes, we entered into Capped Calls, which were not included for purposes of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes. We have not exercised any of the Capped Calls as of January 31, 2023. The following table summarizes the potentially dilutive securities outstanding as of January 31, 2023 and 2022 that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: January 31, 2023 2022 (in thousands) Unvested RSUs and shares of common stock 6,747 6,843 Stock options 1,444 1,921 Unvested PSAs (1) 721 835 Share purchase rights under the ESPP 796 798 Notes 7,626 7,626 Total 17,334 18,023 (1)

Subsequent Events

Subsequent Events	6 Months Ended
Subsequent Events	Jan. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Acquisition of Canonic Security Technologies, Ltd. In February 2023, we completed the acquisition of Canonic Security Technologies, Ltd. (“Canonic”), an early-stage technology company incorporated in Israel. We plan to integrate Canonic’s technology into our cloud platform. Pursuant to the terms of the purchase agreement, the purchase consideration totaled approximately $20.3 million before adjustments, as defined. Certain Canonic employees, who became our employees, are entitled to receive deferred purchase consideration payable in the form of shares of our authorized common stock, which are subject to future employment services . A dditionally, we committed to issue to certain Canonic employees, who became our employees, RSUs and PSAs with an aggregated estimated value of $5.3 million at closing, which are subject to future employment services. The purchase consideration for the acquired business will be allocated to the assets acquired and liabilities assumed based on their respective estimated fair values on the closing date. Due to the timing of the acquisition, the initial accounting for the acquisition is incomplete. As such, we are not able to disclose certain information relating to the acquisition, including the preliminary fair value of assets acquired and liabilities assumed. We expect to complete the initial accounting for this acquisition during the third quarter of fiscal 2023. Restructuring Plan On March 1, 2023, we committed to a plan to restructure and reduce our workforce as a part of our planned efforts to streamline operations and to align people, roles and projects to our strategic priorities. In connection with these actions, we expect to reduce our worldwide headcount by approximately 3%. The reduction in workforce is currently expected to be substantially complete by the end of fiscal 2023. We expect to incur aggregate non-recurring charges of approximately $8.0 million to $10.0 million, consisting primarily of employee severance and benefit costs associated with the restructuring. We expect to recognize the majority of these charges in the third quarter of fiscal 2023.

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2022 (the "Fiscal 2022 Form 10-K"), as filed with the SEC on September 15, 2022.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal use software development costs, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value and effective interest rate of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including effects of COVID-19 and inflation, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained .
Fiscal Year	Fiscal Year Our fiscal year ends on July 31. References to fiscal 2023, for example, refer to our fiscal year ending July 31, 2023.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2020, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06"). This standard removes the separation model for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. We adopted this standard effective on August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. In accordance with the adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. This standard resulted in our convertible senior notes being accounted for as a single unit of debt and we will no longer be required to record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. Prior to the adoption of this standard, we used the treasury stock method to calculate the potentially diluted effect of the convertible

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
Revenue Recognition (Tables)	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) United States $ 193,508 50 % $ 125,419 49 % $ 369,023 50 % $ 238,832 49 % Europe, Middle East and Africa 124,742 32 % 88,174 35 % 241,749 32 % 168,723 35 % Asia Pacific 57,602 15 % 36,029 14 % 109,858 15 % 67,080 14 % Other 11,746 3 % 5,941 2 % 22,516 3 % 11,445 2 % Total $ 387,598 100 % $ 255,563 100 % $ 743,146 100 % $ 486,080 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) Channel partners $ 358,165 92 % $ 238,947 93 % $ 687,522 93 % $ 454,550 94 % Direct customers 29,433 8 % 16,616 7 % 55,624 7 % 31,530 6 % Total $ 387,598 100 % $ 255,563 100 % $ 743,146 100 % $ 486,080 100 %
Capitalized Contract Cost	The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Beginning balance $ 301,472 $ 216,103 $ 297,002 $ 207,030 Capitalization of contract acquisition costs 37,407 34,528 64,202 58,513 Amortization of deferred contract acquisition costs (23,728) (16,126) (46,053) (31,038) Ending balance $ 315,151 $ 234,505 $ 315,151 $ 234,505 The outstanding balance of the deferred contract acquisition costs consisted of the following: January 31, 2023 July 31, 2022 (in thousands) Deferred contract acquisition costs, current $ 96,105 $ 86,210 Deferred contract acquisition costs, noncurrent 219,046 210,792 Total deferred contract acquisition costs $ 315,151 $ 297,002

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	6 Months Ended
Cash Equivalents and Short-Term Investments (Tables)	Jan. 31, 2023
Cash and Cash Equivalents [Abstract]
Schedule of Cash Equivalents and Short-Term Investments	Cash equivalents and short-term investments consisted of the following as of January 31, 2023: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 436,581 $ — $ — $ 436,581 U.S. treasury securities 26,933 — (2) 26,931 U.S. government agency securities 369,324 — (79) 369,245 Corporate debt securities 117,303 — — 117,303 Total cash equivalents $ 950,141 $ — $ (81) $ 950,060 Short-term investments: U.S. treasury securities $ 31,533 $ 40 $ — $ 31,573 U.S. government agency securities 276,278 — (6,471) 269,807 Corporate debt securities 350,578 337 (3,963) 346,952 Total short-term investments $ 658,389 $ 377 $ (10,434) $ 648,332 Total cash equivalents and short-term investments $ 1,608,530 $ 377 $ (10,515) $ 1,598,392 Cash equivalents and short-term investments consisted of the following as of July 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 247,613 $ — $ — $ 247,613 U.S. treasury securities 202,778 — (70) 202,708 U.S. government agency securities 135,525 2 (38) 135,489 Corporate debt securities 106,272 — — 106,272 Total cash equivalents $ 692,188 $ 2 $ (108) $ 692,082 Short-term investments: U.S. treasury securities $ 96,089 $ 10 $ (251) $ 95,848 U.S. government agency securities 339,957 6 (6,628) 333,335 Corporate debt securities 293,968 — (5,022) 288,946 Total short-term investments $ 730,014 $ 16 $ (11,901) $ 718,129 Total cash equivalents and short-term investments $ 1,422,202 $ 18 $ (12,009) $ 1,410,211
Schedule of Maturities	The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of January 31, 2023: Amortized Fair Value (in thousands) Due within one year $ 427,636 $ 423,153 Due between one to three years 230,753 225,179 Total $ 658,389 $ 648,332
Schedule of Unrealized Loss on Investments	Short-term investments that were in an unrealized loss position as of January 31, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 24,983 $ — $ — $ — $ 24,983 $ — U.S. government agency securities 75,709 (23) 183,088 (6,448) 258,797 (6,471) Corporate debt securities 49,577 (181) 141,110 (3,782) 190,687 (3,963) Total $ 150,269 $ (204) $ 324,198 $ (10,230) $ 474,467 $ (10,434) Short-term investments that were in an unrealized loss position as of July 31, 2022 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 80,833 $ (251) $ — $ — $ 80,833 $ (251) U.S. government agency securities 230,670 (5,150) 50,134 (1,478) 280,804 (6,628) Corporate debt securities 155,968 (3,947) 71,127 (1,075) 227,095 (5,022) Total $ 467,471 $ (9,348) $ 121,261 $ (2,553) $ 588,732 $ (11,901)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
Fair Value Measurements (Tables)	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis as of January 31, 2023, consisted of the following: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 436,581 $ 436,581 $ — $ — U.S. treasury securities 26,931 — 26,931 — U.S. government agency securities 369,245 — 369,245 — Corporate debt securities 117,303 — 117,303 — Total cash equivalents $ 950,060 $ 436,581 $ 513,479 $ — Short-term investments: U.S. treasury securities $ 31,573 $ — $ 31,573 $ — U.S. government agency securities 269,807 — 269,807 — Corporate debt securities 346,952 — 346,952 — Total short-term investments $ 648,332 $ — $ 648,332 $ — Total cash equivalents and short-term investments $ 1,598,392 $ 436,581 $ 1,161,811 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 7,770 $ — $ 7,770 $ — Foreign currency contract assets-noncurrent (2) $ 5,368 $ — $ 5,368 $ — Foreign currency contracts liabilities-current (3) $ 4,084 $ — $ 4,084 $ — Foreign currency contracts liabilities-noncurrent (4) $ 145 $ — $ 145 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 617 $ — $ 617 $ — Foreign currency contracts liabilities-current (3) $ 2,309 $ — $ 2,309 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis as of January 31, 2023, consisted of the following: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 436,581 $ 436,581 $ — $ — U.S. treasury securities 26,931 — 26,931 — U.S. government agency securities 369,245 — 369,245 — Corporate debt securities 117,303 — 117,303 — Total cash equivalents $ 950,060 $ 436,581 $ 513,479 $ — Short-term investments: U.S. treasury securities $ 31,573 $ — $ 31,573 $ — U.S. government agency securities 269,807 — 269,807 — Corporate debt securities 346,952 — 346,952 — Total short-term investments $ 648,332 $ — $ 648,332 $ — Total cash equivalents and short-term investments $ 1,598,392 $ 436,581 $ 1,161,811 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 7,770 $ — $ 7,770 $ — Foreign currency contract assets-noncurrent (2) $ 5,368 $ — $ 5,368 $ — Foreign currency contracts liabilities-current (3) $ 4,084 $ — $ 4,084 $ — Foreign currency contracts liabilities-noncurrent (4) $ 145 $ — $ 145 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 617 $ — $ 617 $ — Foreign currency contracts liabilities-current (3) $ 2,309 $ — $ 2,309 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.

Property and Equipment and Pu_2

Property and Equipment and Purchased Intangible Assets (Tables)	6 Months Ended
	Jan. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: January 31, 2023 July 31, 2022 (in thousands) Hosting equipment $ 234,101 $ 191,037 Capitalized internal-use software 96,343 72,267 Computers and equipment 7,464 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,024 1,022 Leasehold improvements 7,339 7,339 Total property and equipment, gross 347,582 279,750 Less: Accumulated depreciation and amortization (147,114) (119,117) Total property and equipment, net $ 200,468 $ 160,633

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	6 Months Ended
Goodwill and Acquired Intangible Assets (Tables)	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Intangible Assets	Acquired intangible assets subject to amortization consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount July 31, 2022 Additions January 31, 2023 July 31, 2022 Amortization Expense January 31, 2023 July 31, 2022 January 31, 2023 (in thousands) Developed technology $ 48,356 $ — $ 48,356 $ (18,972) $ (4,747) $ (23,719) $ 29,384 $ 24,637 Customer relationships 3,560 — 3,560 (1,125) (356) (1,481) 2,435 2,079 Total $ 51,916 $ — $ 51,916 $ (20,097) $ (5,103) $ (25,200) $ 31,819 $ 26,716
Schedule of Future Amortization Expense	Future amortization expense of acquired intangible assets consisted of the following: January 31, 2023 Year ending July 31, (in thousands) 2023 (remaining six months) $ 4,817 2024 8,481 2025 7,778 2026 4,232 2027 1,408 Total $ 26,716

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Tables)	6 Months Ended
Derivative Instruments and Hedging Activities (Tables)	Jan. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Cash Flow Hedges on our Consolidated Statement of Operations	The following table presents information about (gains) losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations for three and six months ended January 31, 2023 and 2022 : Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Classification: Cost of revenue $ 706 $ 64 $ 1,413 $ 69 Sales and marketing 2,757 760 6,053 1,140 Research and development 583 24 1,047 (2) General and administrative 221 28 467 24 Total $ 4,267 $ 876 $ 8,980 $ 1,231

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	6 Months Ended
Convertible Senior Notes (Tables)	Jan. 31, 2023
Debt Disclosure [Abstract]
Schedule of Convertible Senior Notes	The net carrying amount of the liability component of the Notes consisted of the following: January 31, July 31, 2023 2022 (in thousands) Principal amount $ 1,149,993 $ 1,149,995 Less: Unamortized debt discount (1) — 172,169 Unamortized debt issuance costs (1) 9,477 9,152 Net carrying amount $ 1,140,516 $ 968,674 (1) Effective August 1, 2022, we adopted ASU 2020-06 using the modified retrospective method under which prior period amounts have not been adjusted. The adoption of this standard resulted in the elimination of the debt discount and related amortization as interest expense and the classification of the portion of the debt issuance costs initially allocated to equity within the carrying amount of our senior convertible notes, which is recognized as interest expense post adoption of the standard. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Contractual interest expense $ 360 $ 359 $ 719 $ 719 Amortization of debt discount (1) — 12,990 — 25,785 Amortization of debt issuance costs (1) 973 691 1,945 1,371 Total $ 1,333 $ 14,040 $ 2,664 $ 27,875 (1) The decrease in total interest expense for the three and six months ended January 31, 2023, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
Stock-Based Compensation (Tables)	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options	The activity of stock options for the six months ended January 31, 2023 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2022 1,673 $ 11.81 2.5 $ 240,286 Exercised (224) 9.20 29,977 Canceled, forfeited or expired (5) 7.61 Balance as of January 31, 2023 1,444 $ 12.24 2.1 $ 161,644 Exercisable and expected to vest as of July 31, 2022 1,501 $ 10.78 2.4 $ 216,539 Exercisable and expected to vest as of January 31, 2023 1,375 $ 11.60 2.1 $ 154,769
Schedule of Restricted Stock Units and Performance Stock Awards Activity	The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the six months ended January 31, 2023: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2022 7,388 $ 157.17 $ 1,145,526 Granted 2,365 157.94 Vested (1,666) 150.83 254,957 Canceled or forfeited (738) 168.08 Balance as of January 31, 2023 7,349 $ 157.76 $ 912,413
Schedule of ESPP Valuation Assumptions	The fair value of the purchase right for the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Six Months Ended January 31, 2023 2022 Expected term (in years) 0.5 -2.0 0.5 - 2.0 Expected stock price volatility 62.4% - 75.9% 44.1% - 57.4% Risk-free interest rate 4.2% - 4.7% 0.1% - 0.7% Dividend yield 0.0% 0.0%
Schedule of Allocation of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended January 31, Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) Cost of revenue $ 9,410 $ 5,481 $ 17,842 $ 10,467 Sales and marketing 54,213 44,586 107,848 85,307 Research and development 29,005 28,626 53,536 55,885 General and administrative 17,110 20,295 35,685 37,232 Total $ 109,738 $ 98,988 $ 214,911 $ 188,891

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
Net Loss Per Share (Tables)	Jan. 31, 2023
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended Six Months Ended January 31, 2023 2022 2023 2022 (in thousands) (in thousands) Net loss $ (57,453) $ (100,420) $ (125,615) $ (191,221) Weighted-average shares used in computing net loss per share, basic and diluted 144,511 140,515 144,001 139,901 Net loss per share, basic and diluted $ (0.40) $ (0.71) $ (0.87) $ (1.37)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table summarizes the potentially dilutive securities outstanding as of January 31, 2023 and 2022 that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: January 31, 2023 2022 (in thousands) Unvested RSUs and shares of common stock 6,747 6,843 Stock options 1,444 1,921 Unvested PSAs (1) 721 835 Share purchase rights under the ESPP 796 798 Notes 7,626 7,626 Total 17,334 18,023 (1)

Business and Summary of Signi_3

Business and Summary of Significant Accounting Policies (Details) shares in Thousands, $ in Thousands	Aug. 01, 2022 USD ($) shares	Jan. 31, 2023 USD ($)	Oct. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)	Jan. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Jul. 31, 2021 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total carrying value		$ 1,149,993		$ 1,149,995
Cumulative effect adjustment		528,657	$ 431,275	573,300	$ 539,367	$ 530,199	$ 528,895
Number of shares if notes converted (in shares) \| shares	7,630
Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment		1,547,203	1,425,156	1,590,885	1,341,346	1,225,224	1,131,006
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment		$ (1,013,654)	$ (956,201)	(991,878)	$ (792,821)	$ (692,401)	$ (601,600)
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total carrying value	$ 169,900
Cumulative effect adjustment				(169,899)
Cumulative Effect, Period of Adoption, Adjustment \| Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	(273,700)			(273,738)
Cumulative Effect, Period of Adoption, Adjustment \| Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	$ 103,800			$ 103,839

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Concentration Risk [Line Items]
Deferred revenue	$ 1,111.9		$ 1,111.9		$ 1,021.1
Contract with customer, liability, revenue recognized			603.8	$ 378.6
Revenue, remaining performance obligation	2,809.2		2,809.2
Accrued sales commissions	$ 23.5		$ 23.5		$ 47.2
Minimum
Concentration Risk [Line Items]
Contract with customer, term of contract			1 year
Maximum
Concentration Risk [Line Items]
Contract with customer, term of contract			3 years
Transferred over Time \| Product Concentration Risk \| Subscription and Support \| Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk percentage	97%	97%	97%	97%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 387,598	$ 255,563	$ 743,146	$ 486,080
Revenue Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 387,598	$ 255,563	$ 743,146	$ 486,080
Revenue percentage	100%	100%	100%	100%
Revenue Benchmark \| Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 387,598	$ 255,563	$ 743,146	$ 486,080
Revenue percentage	100%	100%	100%	100%
Revenue Benchmark \| Customer Concentration Risk \| Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 358,165	$ 238,947	$ 687,522	$ 454,550
Revenue percentage	92%	93%	93%	94%
Revenue Benchmark \| Customer Concentration Risk \| Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 29,433	$ 16,616	$ 55,624	$ 31,530
Revenue percentage	8%	7%	7%	6%
United States \| Revenue Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 193,508	$ 125,419	$ 369,023	$ 238,832
Revenue percentage	50%	49%	50%	49%
Europe, Middle East and Africa \| Revenue Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 124,742	$ 88,174	$ 241,749	$ 168,723
Revenue percentage	32%	35%	32%	35%
Asia Pacific \| Revenue Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 57,602	$ 36,029	$ 109,858	$ 67,080
Revenue percentage	15%	14%	15%	14%
Other \| Revenue Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 11,746	$ 5,941	$ 22,516	$ 11,445
Revenue percentage	3%	2%	3%	2%

Revenue Recognition - Performan

Revenue Recognition - Performance Obligation (Details)	Jan. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	51%
Recognized transaction price period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	96%
Recognized transaction price period	3 years

Revenue Recognition - Capitaliz

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Changes in Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 301,472	$ 216,103	$ 297,002	$ 207,030
Capitalization of contract acquisition costs	37,407	34,528	64,202	58,513
Amortization of deferred contract acquisition costs	(23,728)	(16,126)	(46,053)	(31,038)
Ending balance	315,151	234,505	315,151	234,505
Deferred contract acquisition costs, current	96,105		96,105		$ 86,210
Deferred contract acquisition costs, noncurrent	219,046		219,046		210,792
Total deferred contract acquisition costs	$ 315,151	$ 234,505	$ 315,151	$ 234,505	$ 297,002

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Cash equivalents:
Amortized Cost	$ 950,141	$ 692,188
Unrealized Gains	0	2
Unrealized Losses	(81)	(108)
Fair Value	950,060	692,082
Short-term investments:
Amortized Cost	658,389	730,014
Unrealized Gains	377	16
Unrealized Losses	(10,434)	(11,901)
Fair Value	648,332	718,129
Total cash equivalents and short-term investments, amortized cost	1,608,530	1,422,202
Total cash equivalents and short-term investments, unrealized gains	377	18
Total cash equivalents and short-term investments, unrealized losses	(10,515)	(12,009)
Total cash equivalents and short-term investments	1,598,392	1,410,211
U.S. treasury securities
Short-term investments:
Amortized Cost	31,533	96,089
Unrealized Gains	40	10
Unrealized Losses	0	(251)
Fair Value	31,573	95,848
U.S. government agency securities
Short-term investments:
Amortized Cost	276,278	339,957
Unrealized Gains	0	6
Unrealized Losses	(6,471)	(6,628)
Fair Value	269,807	333,335
Corporate debt securities
Short-term investments:
Amortized Cost	350,578	293,968
Unrealized Gains	337	0
Unrealized Losses	(3,963)	(5,022)
Fair Value	346,952	288,946
Money market funds
Cash equivalents:
Amortized Cost	436,581	247,613
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	436,581	247,613
U.S. treasury securities
Cash equivalents:
Amortized Cost	26,933	202,778
Unrealized Gains	0	0
Unrealized Losses	(2)	(70)
Fair Value	26,931	202,708
U.S. government agency securities
Cash equivalents:
Amortized Cost	369,324	135,525
Unrealized Gains	0	2
Unrealized Losses	(79)	(38)
Fair Value	369,245	135,489
Corporate debt securities
Cash equivalents:
Amortized Cost	117,303	106,272
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	$ 117,303	$ 106,272

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Schedule of Maturities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Amortized Cost
Due within one year	$ 427,636
Due between one to three years	230,753
Amortized Cost	658,389	$ 730,014
Fair Value
Due within one year	423,153
Due between one to three years	225,179
Fair Value	$ 648,332	$ 718,129

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Position (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	$ 150,269	$ 467,471
Less than 12 months, unrealized losses	(204)	(9,348)
Greater than 12 months, fair value	324,198	121,261
Greater than 12 months, unrealized losses	(10,230)	(2,553)
Total fair value	474,467	588,732
Total unrealized losses	(10,434)	(11,901)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	24,983	80,833
Less than 12 months, unrealized losses	0	(251)
Greater than 12 months, fair value	0	0
Greater than 12 months, unrealized losses	0	0
Total fair value	24,983	80,833
Total unrealized losses	0	(251)
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	75,709	230,670
Less than 12 months, unrealized losses	(23)	(5,150)
Greater than 12 months, fair value	183,088	50,134
Greater than 12 months, unrealized losses	(6,448)	(1,478)
Total fair value	258,797	280,804
Total unrealized losses	(6,471)	(6,628)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	49,577	155,968
Less than 12 months, unrealized losses	(181)	(3,947)
Greater than 12 months, fair value	141,110	71,127
Greater than 12 months, unrealized losses	(3,782)	(1,075)
Total fair value	190,687	227,095
Total unrealized losses	$ (3,963)	$ (5,022)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Millions	Jan. 31, 2023	Jul. 31, 2022
Cash and Cash Equivalents [Abstract]
Accrued interest receivable	$ 1.7	$ 1.3
Investment carrying value	$ 6.3	$ 5.1

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Cash equivalents:
Fair Value	$ 950,060	$ 692,082
Short-term investments:
Short-term investments	648,332	718,129
Total cash equivalents and short-term investments	1,598,392	1,410,211
Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	950,060	692,082
Short-term investments:
Short-term investments	648,332	718,129
Total cash equivalents and short-term investments	1,598,392	1,410,211
Fair Value, Measurements, Recurring \| Foreign currency contracts \| Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	7,770	178
Foreign currency contract assets-noncurrent	5,368	17
Foreign currency contracts liabilities-current	4,084	10,921
Foreign currency contracts liabilities-noncurrent	145	588
Non-designated derivative instruments:
Foreign currency contract assets-current	7,770	178
Foreign currency contracts liabilities-current	4,084	10,921
Fair Value, Measurements, Recurring \| Foreign currency contracts \| Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	617	452
Foreign currency contracts liabilities-current	2,309	3,427
Non-designated derivative instruments:
Foreign currency contract assets-current	617	452
Foreign currency contracts liabilities-current	2,309	3,427
Fair Value, Measurements, Recurring \| Level I
Cash equivalents:
Fair Value	436,581	247,613
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	436,581	247,613
Fair Value, Measurements, Recurring \| Level I \| Foreign currency contracts \| Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring \| Level I \| Foreign currency contracts \| Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring \| Level II
Cash equivalents:
Fair Value	513,479	444,469
Short-term investments:
Short-term investments	648,332	718,129
Total cash equivalents and short-term investments	1,161,811	1,162,598
Fair Value, Measurements, Recurring \| Level II \| Foreign currency contracts \| Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	7,770	178
Foreign currency contract assets-noncurrent	5,368	17
Foreign currency contracts liabilities-current	4,084	10,921
Foreign currency contracts liabilities-noncurrent	145	588
Non-designated derivative instruments:
Foreign currency contract assets-current	7,770	178
Foreign currency contracts liabilities-current	4,084	10,921
Fair Value, Measurements, Recurring \| Level II \| Foreign currency contracts \| Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	617	452
Foreign currency contracts liabilities-current	2,309	3,427
Non-designated derivative instruments:
Foreign currency contract assets-current	617	452
Foreign currency contracts liabilities-current	2,309	3,427
Fair Value, Measurements, Recurring \| Level III
Cash equivalents:
Fair Value	0	0
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Fair Value, Measurements, Recurring \| Level III \| Foreign currency contracts \| Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring \| Level III \| Foreign currency contracts \| Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
U.S. treasury securities
Short-term investments:
Short-term investments	31,573	95,848
U.S. treasury securities \| Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	31,573	95,848
U.S. treasury securities \| Fair Value, Measurements, Recurring \| Level I
Short-term investments:
Short-term investments	0	0
U.S. treasury securities \| Fair Value, Measurements, Recurring \| Level II
Short-term investments:
Short-term investments	31,573	95,848
U.S. treasury securities \| Fair Value, Measurements, Recurring \| Level III
Short-term investments:
Short-term investments	0	0
U.S. government agency securities
Short-term investments:
Short-term investments	269,807	333,335
U.S. government agency securities \| Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	269,807	333,335
U.S. government agency securities \| Fair Value, Measurements, Recurring \| Level I
Short-term investments:
Short-term investments	0	0
U.S. government agency securities \| Fair Value, Measurements, Recurring \| Level II
Short-term investments:
Short-term investments	269,807	333,335
U.S. government agency securities \| Fair Value, Measurements, Recurring \| Level III
Short-term investments:
Short-term investments	0	0
Corporate debt securities
Short-term investments:
Short-term investments	346,952	288,946
Corporate debt securities \| Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	346,952	288,946
Corporate debt securities \| Fair Value, Measurements, Recurring \| Level I
Short-term investments:
Short-term investments	0	0
Corporate debt securities \| Fair Value, Measurements, Recurring \| Level II
Short-term investments:
Short-term investments	346,952	288,946
Corporate debt securities \| Fair Value, Measurements, Recurring \| Level III
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Fair Value	436,581	247,613
Money market funds \| Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	436,581	247,613
Money market funds \| Fair Value, Measurements, Recurring \| Level I
Cash equivalents:
Fair Value	436,581	247,613
Money market funds \| Fair Value, Measurements, Recurring \| Level II
Cash equivalents:
Fair Value	0	0
Money market funds \| Fair Value, Measurements, Recurring \| Level III
Cash equivalents:
Fair Value	0	0
U.S. treasury securities
Cash equivalents:
Fair Value	26,931	202,708
U.S. treasury securities \| Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	26,931	202,708
U.S. treasury securities \| Fair Value, Measurements, Recurring \| Level I
Cash equivalents:
Fair Value	0	0
U.S. treasury securities \| Fair Value, Measurements, Recurring \| Level II
Cash equivalents:
Fair Value	26,931	202,708
U.S. treasury securities \| Fair Value, Measurements, Recurring \| Level III
Cash equivalents:
Fair Value	0	0
U.S. government agency securities
Cash equivalents:
Fair Value	369,245	135,489
U.S. government agency securities \| Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	369,245	135,489
U.S. government agency securities \| Fair Value, Measurements, Recurring \| Level I
Cash equivalents:
Fair Value	0	0
U.S. government agency securities \| Fair Value, Measurements, Recurring \| Level II
Cash equivalents:
Fair Value	369,245	135,489
U.S. government agency securities \| Fair Value, Measurements, Recurring \| Level III
Cash equivalents:
Fair Value	0	0
Corporate debt securities
Cash equivalents:
Fair Value	117,303	106,272
Corporate debt securities \| Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	117,303	106,272
Corporate debt securities \| Fair Value, Measurements, Recurring \| Level I
Cash equivalents:
Fair Value	0	0
Corporate debt securities \| Fair Value, Measurements, Recurring \| Level II
Cash equivalents:
Fair Value	117,303	106,272
Corporate debt securities \| Fair Value, Measurements, Recurring \| Level III
Cash equivalents:
Fair Value	$ 0	$ 0

Property and Equipment and Pu_3

Property and Equipment and Purchased Intangible Assets - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 347,582	$ 279,750
Less: Accumulated depreciation and amortization	(147,114)	(119,117)
Total property and equipment, net	200,468	160,633
Hosting equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	234,101	191,037
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	96,343	72,267
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	7,464	6,774
Purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,311	1,311
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,024	1,022
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 7,339	$ 7,339

Property and Equipment and Pu_4

Property and Equipment and Purchased Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	$ 51,916		$ 51,916		$ 51,916
Accumulated amortization	25,200		25,200		20,097
Depreciation and amortization expense	13,400	$ 10,000	25,241	$ 19,005
Capitalization of development costs of software for internal-use	109,738	98,988	$ 214,911	188,891
IP Addresses
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life			10 years
Historical cost	8,600		$ 8,600		6,400
Accumulated amortization	1,200		1,200		$ 800
Capitalized internal-use software
Acquired Finite-Lived Intangible Assets [Line Items]
Capitalization of development costs of software for internal-use	$ 2,000	$ 1,000	$ 3,700	$ 1,900

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 78,547		$ 78,547		$ 78,547
Amortization expense of acquired intangible assets	$ 2,600	$ 2,200	$ 5,103	$ 4,457

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			$ 51,916
Additions			0
Intangible Assets, Gross, ending balance	$ 51,916		51,916
Accumulated Amortization, beginning balance			(20,097)
Amortization Expense	(2,600)	$ (2,200)	(5,103)	$ (4,457)
Accumulated Amortization, ending balance	(25,200)		(25,200)
Total	26,716		26,716		$ 31,819
Developed technology
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			48,356
Additions			0
Intangible Assets, Gross, ending balance	48,356		48,356
Accumulated Amortization, beginning balance			(18,972)
Amortization Expense			(4,747)
Accumulated Amortization, ending balance	(23,719)		(23,719)
Total	24,637		24,637		29,384
Customer relationships
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			3,560
Additions			0
Intangible Assets, Gross, ending balance	3,560		3,560
Accumulated Amortization, beginning balance			(1,125)
Amortization Expense			(356)
Accumulated Amortization, ending balance	(1,481)		(1,481)
Total	$ 2,079		$ 2,079		$ 2,435

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remaining six months)	$ 4,817
2024	8,481
2025	7,778
2026	4,232
2027	1,408
Total	$ 26,716	$ 31,819

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Derivative [Line Items]
Unrealized losses related to our cash flow hedges			$ 2,900
Gain (loss) recognized on cash flow hedges	$ (24,019)	$ 3,164	$ (9,980)	$ 4,469
Maximum
Derivative [Line Items]
Term of derivative			24 months
Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	409,200		$ 409,200		$ 293,400
Not Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	$ 156,200		$ 156,200		$ 126,400
Foreign currency contracts \| Not Designated as Hedging Instrument \| Minimum
Derivative [Line Items]
Term of derivative	1 month		1 month
Foreign currency contracts \| Not Designated as Hedging Instrument \| Maximum
Derivative [Line Items]
Term of derivative		4 months		4 months

Derivative Instruments - Cash F

Derivative Instruments - Cash Flow Hedges on our Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 4,267	$ 876	$ 8,980	$ 1,231
Cost of revenue
Derivative Instruments, Gain (Loss) [Line Items]
Total	706	64	1,413	69
Sales and marketing
Derivative Instruments, Gain (Loss) [Line Items]
Total	2,757	760	6,053	1,140
Research and development
Derivative Instruments, Gain (Loss) [Line Items]
Total	583	24	1,047	(2)
General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 221	$ 28	$ 467	$ 24

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details) - USD ($)	Jun. 25, 2020	Jan. 31, 2023	Jul. 31, 2022
Debt Instrument [Line Items]
Proceeds from debt issuance	$ 1,130,500,000
Fair value of notes		$ 1,259,900,000	$ 1,418,500,000
Initial strike price (in dollars per share)	$ 150.80
Initial cap price (in dollars per shares)	$ 246.76
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal amount	$ 1,150,000,000
Interest rate	0.125%
Convertible Senior Notes, $150 million
Debt Instrument [Line Items]
Principal amount	$ 150,000,000

Convertible Senior Notes - Carr

Convertible Senior Notes - Carrying Amounts (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Convertible Debt [Abstract]
Principal amount	$ 1,149,993	$ 1,149,995
Unamortized debt discount	0	172,169
Unamortized debt issuance costs	9,477	9,152
Net carrying amount	$ 1,140,516	$ 968,674

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 360	$ 359	$ 719	$ 719
Amortization of debt discount	0	12,990	0	25,785
Amortization of debt issuance costs	973	691	1,945	1,371
Total	$ 1,333	$ 14,040	$ 2,664	$ 27,875

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Jan. 31, 2023	Jul. 31, 2022
Letter of Credit
Loss Contingencies [Line Items]
Aggregate value of unsecured letters of credits	$ 2.1	$ 2.1

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended		12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Outstanding Stock Options
Beginning balance (in shares)	1,673
Exercised (in shares)	(224)
Canceled, forfeited or expired (in shares)	(5)
Ending balance (in shares)	1,444		1,673
Exercisable and expected to vest (in shares)	1,375		1,501
Weighted-Average Exercise Price
Beginning balance (in dollars per share)	$ 11.81
Exercised (in dollars per share)	9.20
Canceled, forfeited or expired (in dollars per share)	7.61
Ending balance (in dollars per share)	12.24		$ 11.81
Exercisable and expected to vest (in dollars per share)	$ 11.60		$ 10.78
Additional Disclosures
Options outstanding, weighted average remaining contractual term	2 years 1 month 6 days		2 years 6 months
Exercisable and expected to vest, weighted average remaining contractual term	2 years 1 month 6 days		2 years 4 months 24 days
Options outstanding, aggregate intrinsic value	$ 161,644		$ 240,286
Exercised, aggregate intrinsic value	29,977	$ 182,600
Exercisable and expected to vest, aggregate intrinsic value	$ 154,769		$ 216,539

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercised, aggregate intrinsic value				$ 29,977	$ 182,600
Granted (in shares)				0	0
Incremental compensation cost				$ 5,600
Reversal of stock-based compensation		$ 109,738	$ 98,988	214,911	$ 188,891
Capitalized stock-based compensation		$ 4,300	$ 2,700	8,300	$ 5,200
President
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of stock-based compensation				$ (9,900)
2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average purchase price per share (in dollars per share)		$ 99.59		$ 99.59
Performance stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares outstanding (in shares)		100,000		100,000
Employee Stock \| 2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued (in shares)		100,000
Cash proceeds from the issuance of common stock		$ 11,400
Accrued compensation		$ 9,200		$ 9,200		$ 4,700
Incremental compensation cost	$ 8,300
Employee Stock \| 2018 Employee Stock Purchase Plan \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average	6 months
Employee Stock \| 2018 Employee Stock Purchase Plan \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average	18 months

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of RSU and PSA Activity (Details) - Restricted Stock Units and Performance Stock Awards - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Jan. 31, 2023	Jul. 31, 2022
Underlying Shares
Beginning balance (in shares)	7,388
Granted (in shares)	2,365
Vested (in shares)	(1,666)
Canceled or forfeited (in shares)	(738)
Ending balance (in shares)	7,349
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 157.17
Granted (in dollars per share)	157.94
Vested (in dollars per share)	150.83
Canceled or forfeited (in shares)	168.08
Ending balance (in dollars per share)	$ 157.76
Aggregate Intrinsic Value
Balance	$ 912,413	$ 1,145,526
Vested	$ 254,957

Stock-Based Compensation - Valu

Stock-Based Compensation - Valuation Assumptions (Details) - Employee Stock	6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected stock price volatility, minimum	62.40%	44.10%
Expected stock price volatility, maximum	75.90%	57.40%
Risk-free interest rate, minimum	4.20%	0.10%
Risk-free interest rate, maximum	4.70%	0.70%
Dividend yield	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years	2 years

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	$ 109,738	$ 98,988	$ 214,911	$ 188,891
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	9,410	5,481	17,842	10,467
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	54,213	44,586	107,848	85,307
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	29,005	28,626	53,536	55,885
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	$ 17,110	$ 20,295	$ 35,685	$ 37,232

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Provision (benefit) for income taxes	$ 3,692	$ 2,161	$ 8,438	$ 4,640

Net Loss Per Share - Net Loss P

Net Loss Per Share - Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Earnings Per Share [Abstract]
Net loss, basic	$ (57,453)	$ (100,420)	$ (125,615)	$ (191,221)
Net loss, diluted	$ (57,453)	$ (100,420)	$ (125,615)	$ (191,221)
Weighted-average shares used in computing net loss per share, basic (in shares)	144,511	140,515	144,001	139,901
Weighted-average shares used in computing net loss per share, diluted (in shares)	144,511	140,515	144,001	139,901
Net loss per share, basic (in dollars per share)	$ (0.40)	$ (0.71)	$ (0.87)	$ (1.37)
Net loss per share, diluted (in dollars per share)	$ (0.40)	$ (0.71)	$ (0.87)	$ (1.37)

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	Jan. 31, 2023 $ / shares
Earnings Per Share [Abstract]
Conversion price (in dollars per share)	$ 150.80

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation (Details) - shares shares in Thousands	6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	17,334	18,023
Unvested RSUs and shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	6,747	6,843
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,444	1,921
Unvested PSAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	721	835
Number of unvested PSAs as a percentage of target	100%	100%
Share purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	796	798
Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	7,626	7,626

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - USD ($) $ in Millions	1 Months Ended
	Feb. 28, 2023	Mar. 01, 2023
Subsequent Event [Line Items]
Worldwide workforce reduction percentage		3%
Minimum
Subsequent Event [Line Items]
Aggregate non-recurring charges		$ 8
Maximum
Subsequent Event [Line Items]
Aggregate non-recurring charges		$ 10
Canonic Security Technologies, Ltd
Subsequent Event [Line Items]
Purchase price	$ 20.3
Canonic Security Technologies, Ltd \| Onboarding Employees \| RSUs and PSAs
Subsequent Event [Line Items]
Payable in shares	$ 5.3